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(Vol_dif = Vol_treatment – Vol_CT) could potentially 
influence the pass rate negatively. Association between 
Vol_dif and gamma pass rates was analysed by linear 
regression between the gamma pass rates and Vol_dif 
squared. In order to adjust at least partially for the residual 
setup uncertainty, the regression was performed including 
the fraction number as predictor variable since fields within 
a fraction are assumed to have the same setup uncertainty. 
 
Results: Difference between pass rates for the ABC and non-
ABC group was highly statistically significant (p<0.001), with 
median pass rates of 84.7% and 76.1%, respectively (see 
figure). However, within the ABC group no significant 
association was observed between pass rates and deviation of 
inhaled air relative to the reference from the planning CT. 
EPID images were used to evaluate patient positioning prior 
to treatment and only accepted if deviations were less than 5 
mm. Thus, it seems likely that the residual positioning 
uncertainty is the dominant uncertainty relative to the 
uncertainty in breath-hold volume when using ABC. 
 
 
 
Conclusion: Breast cancer patients treated with the use of 
ABC showed an improved EPID dosimetry pass rate, reflecting 
an improved accuracy of dose delivery. However, a potential 
patient selection bias exists since no randomization between 
groups was performed. No significant association was 
observed between Vol_dif and pass rate within the ABC 
group. The ABC system therefore performs as intended and 
errors in breath-hold volumes are not of concern given the 
residual setup uncertainties. 
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Purpose or Objective: Intra-fraction motion of the prostate 
during irradiation requires large PTV margins. The recently 
released imaging application Triggered Imaging (TI, Varian 
Medical Systems, Palo Alto CA) allows to generate 2D kV 
images at predefined intervals during irradiation. The 
application can automatically detect implanted fiducial 
markers and initiate beam interrupt. Our previous work 
shows that re-setup was justified for almost half of the beam 
interrupts based on a 6mm tolerance. This study describes 
how applying TI and re-setup in the clinical workflow resulted 
in the reduction of the PTV margin. 
 
Material and Methods: A total of 96 prostate cancer patients 
with implanted gold seeds were treated on the Truebeam 
with two RapidArc beams (Software version 2.0, Varian 
Medical Systems, Palo Alto, CA). For patient setup, the gold 
seeds are lined up using two orthogonal 2D kV images. After 
the setup procedure, TI is applied during both beams at an 
interval of 3 seconds, resulting in 41 images per fraction.In 
the plannings CT, the center of gravity of each seed is 
defined as a Marker. During treatment, each seed is 
automatically detected on each acquired Triggered Image 
and its center of gravity is marked with a cross. A circular 
overlay centered at the Marker position is projected on each 
Triggered Image. The radius of this circle indicates the 
maximum allowed seed deviation and is referred to as the TI 
limit. A color coding is used to indicate whether the seed is 
in or outside the TI limit (Fig 1).If one or more gold seeds 
exceed the limit for more than 6 seconds the beam is 
manually paused, while TI continues at the same gantry 
angle. If the deviation persists for another 6 seconds, the 
beam is interrupted and re-setup is performed using two 
orthogonal 2D kV images.For a first group of patients (n=27) 
TI was used, with the TI limit set to 6mm which corresponds 
to the PTV margin. For a second group of patients (n=32) the 
TI limit is set to 5mm, with an unchanged PTV margin of 
6mm. For a third group (n=37) the PTV margin was reduced 
to 5mm, along with a TI limit of 5mm.  
 
 
 
Results: For the total of 1434 fractions, 134 fractions showed 
excessive intra-fraction motion of one or more gold seeds 
leading to 173 beam interruptions and re-setups. Translations 
applied in re-setup were on average: 3mm, 3mm and 1mm in 
ventrodorsal, longitudinal and lateral directions, 
respectively. Overall, the average shift magnitude was 5mm 
(SD: 2.2mm) with a maximum of 13mm. Shift magnitudes 
exceeding the PTV margin were considered justified. Table 1 
shows that a TI limit that equals the PTV margin leads to 
about 45% of justified interruptions.  
 
 
 
Conclusion: Triggered Imaging in combination with auto-
detection provides a powerful tool to monitor tumor motion 
during treatment for patients with implanted fiducial 
markers. We have developed a strategy for intra-fraction re-
setup allowing for PTV margin reduction with limited increase 
in workload. 
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Purpose or Objective: In SBRT it is typical to prescribe a 
lower dose to an isodose-line encompassing the PTV rim 
rather than prescribing a uniform PTV dose. This strategy 
may allow for a higher central tumor dose than achievable by 
conventional homogenous dose prescription while maintaining 
an acceptable risk of normal tissue toxicity. However, the 
tumor dose may deteriorate because of intra-fraction motion. 
The aim of this study was to determine an optimal dose 
prescription strategy when explicitly considering the effects 
of intra-treatment motion in liver SBRT. 
 
Material and Methods: Six patients received liver SBRT in 3 
fractions. The PTV was generated from the CTV by adding 
margins of 5mm (LR,AP) and 10mm (CC). The 3-D motion of 
an implanted gold marker was monitored throughout each 
fraction by fluoroscopic kV and MV imaging. Later, five VMAT 
treatment plans with different PTV dose coverage were 
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produced for each patient. All plans had a mean CTV dose of 
18.75 Gy per fraction (=100% dose) and 95% minimum CTV 
dose coverage. The PTV was covered by 50%, 67%_S, 67% (our 
standard), 80%, and 95% of the prescribed dose, respectively. 
The 67%_S plan was an alternative to the standard 67% plan 
made with maximum conformity, i.e. as steep as possible 
dose gradient from 95% to 67% outside the CTV. The 50%, 
67%_S, 80%, and 95% plans were renormalized to be isotoxic 
with the standard 67% plan, i.e. to give the same risk of 
radiation induced liver disease (RILD) according to the NTCP-
model of Dawson et al. (Acta Oncol., 2006). For each patient 
and plan, the dosimetric effects of the observed intrafraction 
motion were investigated by calculating the delivered dose 
by an in-house developed method for motion-including dose 
reconstruction. 
 
Results: The figure shows the CTV mean dose and D99 for 
each plan type and each patient as planned (start of each 
arrow) and as delivered with the known tumor motion (end of 
each arrow). The mean values over all patients are presented 
in Table 1. The planned CTV dose decreased markedly from 
63.3Gy to 47.0Gy (average mean dose) and from 60.5Gy to 
44.9Gy (average D99) as the prescription level to the PTV rim 
was increased from 50% to 95%. Although intrafraction motion 
reduced this CTV dose difference the CTV dose of plans with 
high PTV prescription levels remained inferior to isotoxic 
plans with low PTV prescription levels even when motion was 
included in the dose calculations, see Table 1. The absolute 
dose delivered to the liver was almost unaffected by 
intrafraction motion as seen in Table 1. 
 
 
Conclusion: The dose level at the PTV rim has a large effect 
on the risk of RILD. Using a low dose at the PTV rim, where 
the probability of CTV presence during treatment was low, 
allowed for higher CTV dose for iso-toxic conditions in 50% 
and 67%_S plans. Although these plans were less robust to 
intra-fraction motion, their CTV dose remained superior to 
the 80% and 95% plans when motion effects were included. 
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Purpose or Objective: To describe the commissioning 
process and initial experience using real-anatomy, real-time 
tracking and gating with MRI-guided radiation therapy. 
 
Material and Methods: An MR-IGRT system was commissioned 
to enable real-time anatomy tracking and gating. The 
imaging rate is 4 frames per second; the radiation shuts off 
when the anatomy of interest is automatically detected 
outside a pre-defined treatment region. The specific 
commissioning tests were driven by the goal of compensating 
for the inherent system latency such that there would not be 
an increase in treatment margins (i.e., GTV to PTV 
expansion). Dosimetric and geometric accuracy was 
evaluated by using both a commercial and an in-house motion 
phantoms with film and ionization chamber dosimetry. 
Clinical procedures were developed to maintain the 
established accuracy during actual patient treatments. 
 
Results: Since initial clinical implementation, 51 patients 
have been treated using the gating and tracking capability of 
the MR-IGRT system (out of a total of 193). Based on system 
characteristics established during commissioning tests, the 
standard-of-care GTV to PTV expansion was maintained (e.g., 
5 mm for abdominal tumors). Dosimetric accuracy was 
established via ionization chamber measurements that 
showed a 1.28%±1.7% average difference when comparing 
gated (with motion) vs. non-gated (without motion) delivery 
for typical IMRT and open field plans. Spatial accuracy was 
established via film dosimetric measurements and spatial 
integrity measurements to be on the order of 2 mm. This 
level of accuracy is maintained during patient delivery by 
using the following procedure: setting up to an exhale 
breath-hold position and using a gating boundary around the 
region of interest that's 2 mm less than the PTV of interest 
(e.g., 3 mm expansion of the GTV if a 5-mm expansion to 
PTV). Depending on the location of the tumor (or other 
anatomy of interest), duty cycles so far have ranged from 
about 50% (especially for tumors close to diaphragm) to 
about 80% (for pancreatic lesions and other abdominal sites 
excluding liver). Examples are shown in figure below. 
 
